{"id":58477,"date":"2026-02-26T09:26:18","date_gmt":"2026-02-26T09:26:18","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/active-pharmaceutical-ingredients-cdmo-market-mordor\/"},"modified":"2026-09-18T03:38:44","modified_gmt":"2026-09-17T18:38:44","slug":"active-pharmaceutical-ingredients-cdmo-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/active-pharmaceutical-ingredients-cdmo-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc6d0\ub8cc\uc758\uc57d\ud488 CDMO \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/active-pharmaceutical-ingredients-cdmo-market-1718687205047-Picture2.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/active-pharmaceutical-ingredients-cdmo-market-size-image-1770807942421.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uae00\ub85c\ubc8c \uc758\uc57d\ud488 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5\uc73c\ub85c \uc778\ud55c API \uc0dd\uc0b0 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uace0\ud6a8\ub2a5 \ubc0f \ubcf5\ud569 \ubd84\uc790\ub85c\uc758 \uc804\ud658\uc774 CDMO \uc218\uc694 \uc99d\ub300<\/li>\n<li class=\"toc-level-3\">4.2.3 \ud488\uc9c8 \ubc0f \uaddc\uc815 \uc900\uc218\uc5d0 \ub300\ud55c \uaddc\uc81c \uc555\ub825\uc73c\ub85c \ud30c\ud2b8\ub108\uc2ed \uc7a5\ub824<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc544\uc6c3\uc18c\uc2f1 \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \uc720\uc5f0\uc131\uc744 \ud1b5\ud55c \ube44\uc6a9 \ucd5c\uc801\ud654<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud601\uc2e0\uc801\uc778 \uc81c\uc870 \uae30\uc220 \ucc44\ud0dd<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc9c0\uc18d \uac00\ub2a5\uc131 \ubc0f \ud0c4\uc18c \uac10\ucd95 \ubaa9\ud45c\uac00 \uacf5\uae09\uc5c5\uccb4 \uc120\uc815\uc5d0 \uc601\ud5a5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ud575\uc2ec \uc6d0\ub8cc\uc5d0 \ub300\ud55c \uacf5\uae09\ub9dd \ucde8\uc57d\uc131<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc81c\ub124\ub9ad \uc758\uc57d\ud488\uc758 \uac00\uaca9 \ud558\ub77d\uc73c\ub85c \ub9c8\uc9c4 \uc555\ubc15<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc5c4\uaca9\ud55c \ud658\uacbd \ubc0f \uc548\uc804 \uaddc\uc815 \uc900\uc218 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc219\ub828\ub41c \uacf5\uc815 \ud654\ud559\uc790 \ubc0f \uc5d4\uc9c0\ub2c8\uc5b4 \ubd80\uc871<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ubd84\uc790 \ud06c\uae30\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc800\ubd84\uc790<\/li>\n<li class=\"toc-level-3\">5.1.2 \uace0\ubd84\uc790 \/ \uc0dd\ubb3c\ud559\uc801 \ubd84\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ud569\uc131 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud569\uc131 \ud654\ud559\ubb3c\uc9c8<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc0dd\ubb3c\ud559\uc801 (\ubc1c\ud6a8 \/ \uc138\ud3ec \ubc30\uc591)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 API \ubcf5\uc7a1\uc131\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ud45c\uc900 \ud6a8\ub2a5 API<\/li>\n<li class=\"toc-level-3\">5.3.2 \uace0\ud6a8\ub2a5 API (HPAPI)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uacf5\uc815 R&amp;D \ubc0f \uacbd\ub85c \ud0d0\uc0c9<\/li>\n<li class=\"toc-level-3\">5.4.2 cGMP \uc2a4\ucf00\uc77c\uc5c5 \ubc0f \uc0c1\uc5c5 \uc0dd\uc0b0<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud1b5\ud569 \uc5d4\ub4dc\ud22c\uc5d4\ub4dc \uc11c\ube44\uc2a4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uce58\ub8cc \uc601\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc2ec\ud608\uad00 \ubc0f \ub300\uc0ac<\/li>\n<li class=\"toc-level-3\">5.5.3 \ud56d\uac10\uc5fc\uc81c<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ucd94\uc2e0\uacbd\uacc4<\/li>\n<li class=\"toc-level-3\">5.5.5 \ud638\ud761\uae30<\/li>\n<li class=\"toc-level-3\">5.5.6 \uc704\uc7a5 \ubc0f \uac04\uc7a5\ud559<\/li>\n<li class=\"toc-level-3\">5.5.7 \ud53c\ubd80\uacfc \ubc0f \ubbf8\uc6a9<\/li>\n<li class=\"toc-level-3\">5.5.8 \uba74\uc5ed\ud559 \ubc0f \ud76c\uadc0 \uc9c8\ud658<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uace0\uac1d \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ub300\ud615 \uc81c\uc57d\uc0ac<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc911\uacac \uc81c\uc57d\uc0ac<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\ud14d<\/li>\n<li class=\"toc-level-3\">5.6.4 \uae30\ud0c0 \uace0\uac1d \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.7 \ub2e8\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.7.1 \uc804\uc784\uc0c1<\/li>\n<li class=\"toc-level-3\">5.7.2 1\uc0c1<\/li>\n<li class=\"toc-level-3\">5.7.3 2\uc0c1<\/li>\n<li class=\"toc-level-3\">5.7.4 3\uc0c1<\/li>\n<li class=\"toc-level-3\">5.7.5 \uc0c1\uc5c5\ud654<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.8 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.8.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.8.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.8.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.8.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.8.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.8.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.8.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.8.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.8.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.8.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.8.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.8.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.8.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.8.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.8.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.8.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.8.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.8.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.8.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.8.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.8.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.8.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.8.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.8.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.8.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.8.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 {(\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uac00\uc6a9 \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \uadf8\ub9ac\uace0 \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ud3ec\ud568)}\n<ul>\n<li class=\"toc-level-3\">6.3.1 Ajinomoto Bio-Pharma Services<\/li>\n<li class=\"toc-level-3\">6.3.2 Albany Molecular Research Inc. (AMRI)<\/li>\n<li class=\"toc-level-3\">6.3.3 Almac Group<\/li>\n<li class=\"toc-level-3\">6.3.4 Asymchem Laboratories<\/li>\n<li class=\"toc-level-3\">6.3.5 Cambrex Corporation<\/li>\n<li class=\"toc-level-3\">6.3.6 Catalent Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 CordenPharma International<\/li>\n<li class=\"toc-level-3\">6.3.8 EuroAPI<\/li>\n<li class=\"toc-level-3\">6.3.9 Evonik Health Care<\/li>\n<li class=\"toc-level-3\">6.3.10 Hikal Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.11 Hovione<\/li>\n<li class=\"toc-level-3\">6.3.12 Jubilant Pharmova<\/li>\n<li class=\"toc-level-3\">6.3.13 Lonza Group AG<\/li>\n<li class=\"toc-level-3\">6.3.14 Novasep<\/li>\n<li class=\"toc-level-3\">6.3.15 Olon S.p.A<\/li>\n<li class=\"toc-level-3\">6.3.16 Piramal Pharma Solutions<\/li>\n<li class=\"toc-level-3\">6.3.17 Recipharm AB<\/li>\n<li class=\"toc-level-3\">6.3.18 Sai Life Sciences<\/li>\n<li class=\"toc-level-3\">6.3.19 Samsung Biologics<\/li>\n<li class=\"toc-level-3\">6.3.20 Siegfried Holding AG<\/li>\n<li class=\"toc-level-3\">6.3.21 Sterling Pharma Solutions<\/li>\n<li class=\"toc-level-3\">6.3.22 Thermo Fisher Scientific Inc. (Patheon)<\/li>\n<li class=\"toc-level-3\">6.3.23 WuXi AppTec Co., Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc6d0\ub8cc\uc758\uc57d\ud488(API) CDMO \uc2dc\uc7a5 \uac1c\uc694: 2026-2031\ub144 \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd<\/p>\n<p>\uc6d0\ub8cc\uc758\uc57d\ud488(API) CDMO(Contract Development and Manufacturing Organization) \uc2dc\uc7a5\uc740 2025\ub144 1,282\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 1,393\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 8.61%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 2031\ub144\uc5d0\ub294 2,105\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc784\uc0c1 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud655\uc7a5, \uaddc\uc81c \uac10\ub3c5 \uac15\ud654, \uc8fc\uc694 \uc2dc\uc7a5\uc5d0\uc11c\uc758 \uc9c0\uc18d\uac00\ub2a5\uc131 \uc758\ubb34\ud654 \ub4f1\uc73c\ub85c \uc778\ud574 \uc81c\uc57d\uc0ac\ub4e4\uc774 \ubcc0\ub3d9\ube44 \uae30\ubc18\uc758 \uc544\uc6c3\uc18c\uc2f1\uc73c\ub85c \uc804\ud658\ud558\uace0 \uc788\ub294 \ucd94\uc138\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4.<\/p>\n<p>\ud2b9\ud788, 2024\ub144 9\uc6d4 \ubbf8\uad6d \ud558\uc6d0\uc744 \ud1b5\uacfc\ud55c BIOSECURE Act\ub294 \uad6c\ub9e4\uc790\ub4e4\uc774 \uc911\uad6d\uc73c\ub85c\ubd80\ud130 \uacf5\uae09\ub9dd\uc744 \ub2e4\ubcc0\ud654\ud568\uc5d0 \ub530\ub77c \uc9c0\ub9ac\uc801 \uc18c\uc2f1 \ud328\ud134\uc744 \uc7ac\ud3b8\ud558\uace0 \uc788\uc73c\uba70, \uc778\ub3c4\ub294 \uc5ec\uc804\ud788 \ubbf8\uad6d FDA \uc758\uc57d\ud488 \ub9c8\uc2a4\ud130 \ud30c\uc77c(DMF) \ub4f1\ub85d\uc5d0\uc11c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. GLP-1 \uc218\uc6a9\uccb4 \uc791\uc6a9\uc81c\uc640 \uac19\uc740 \ubcf5\ud569 \ud3a9\ud0c0\uc774\ub4dc\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \uc81c\uc57d\uc73c\ub85c \uc778\ud574 \ubc14\ucf10(Bachem)\uacfc \uac19\uc740 \uc120\ub3c4 \uacc4\uc57d\uc5c5\uccb4\ub4e4\uc740 2024-2025\ub144\uc5d0 \uc720\ub7fd\uc5d0 6\uc5b5 \uc2a4\uc704\uc2a4 \ud504\ub791(\uc57d 6\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec)\uc744 \ud22c\uc790\ud558\uc5ec \uc2e0\uaddc \uacf5\uc7a5\uc744 \uac74\uc124\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud55c\ud3b8, 2027\ub144\ubd80\ud130 \uc2dc\ud589\ub418\ub294 \uc720\ub7fd\uc758 \ud0c4\uc18c \ubc30\ucd9c \uacf5\uac1c \uaddc\uc815\uc740 \uc6a9\ub9e4 \uc0ac\uc6a9 \ubc0f \uc628\uc2e4\uac00\uc2a4 \ubc30\ucd9c\uc744 \uc904\uc774\ub294 \uc5f0\uc18d \ud750\ub984 \ubc0f \uc0dd\uccb4 \ucd09\ub9e4 \uacf5\uc815\uc758 \ucc44\ud0dd\uc744 \uac00\uc18d\ud654\ud558\uc5ec \uae30\uc220 \uc120\ub3c4 \uae30\uc5c5\ub4e4\uc5d0\uac8c \uc120\uc810 \ud6a8\uacfc\ub97c \uc81c\uacf5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ud1b5\uacc4:<br \/>\n*   \uc5f0\uad6c \uae30\uac04: 2020\ub144 \u2013 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 1,393\uc5b5 \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 2,105\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031\ub144): \uc5f0\ud3c9\uade0 8.61%<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8\ubcc4 \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d:<br \/>\n*   \ubd84\uc790 \ud06c\uae30\ubcc4: \uc18c\ubd84\uc790(Small Molecule)\uac00 2025\ub144 \ub9e4\ucd9c\uc758 64.51%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ub300\ubd84\uc790\/\uc0dd\ubb3c\ud559\uc801 \ubd84\uc790(Large\/Biologic Molecule)\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 10.54%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ud569\uc131 \uc720\ud615\ubcc4: \ud654\ud559 \ud569\uc131(Synthetic Chemical)\uc774 2025\ub144 71.54%\ub97c \ucc28\uc9c0\ud588\uace0, \uc0dd\ubb3c\ud559\uc801 \ud569\uc131(Biological, \ubc1c\ud6a8\/\uc138\ud3ec \ubc30\uc591)\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 10.88%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   API \ubcf5\uc7a1\uc131\ubcc4: \ud45c\uc900 \ud6a8\ub2a5 API(Standard-Potency APIs)\uac00 2025\ub144 75.76%\ub97c \uc810\uc720\ud588\uc73c\uba70, \uace0\ud6a8\ub2a5 API(Highly-Potent APIs, HPAPIs)\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.32%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4: cGMP \uc2a4\ucf00\uc77c\uc5c5 \ubc0f \uc0c1\uc5c5 \uc0dd\uc0b0(cGMP scale-up &#038; commercial manufacturing)\uc774 2025\ub144 65.76%\ub97c \ucc28\uc9c0\ud588\uace0, \ud1b5\ud569 \uc5d4\ub4dc\ud22c\uc5d4\ub4dc \uc11c\ube44\uc2a4(Integrated end-to-end services)\ub294 \uac19\uc740 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 10.33%\ub85c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc601\uc5ed\ubcc4: \uc885\uc591\ud559(Oncology)\uc774 2025\ub144 33.76%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uba74\uc5ed\ud559 \ubc0f \ud76c\uadc0 \uc9c8\ud658(Immunology &#038; Rare Diseases)\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.76%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uace0\uac1d \uc720\ud615\ubcc4: \ub300\ud615 \uc81c\uc57d\uc0ac(Big Pharma)\uac00 2025\ub144 53.76%\uc758 \uc810\uc720\uc728\ub85c \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud588\uc73c\uba70, \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\ud14d(Small Biotech) \uae30\uc5c5\ub4e4\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 10.76%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ub2e8\uacc4\ubcc4: \uc0c1\uc5c5 \ud504\ub85c\uc81d\ud2b8(Commercial projects)\uac00 2025\ub144 48.54%\ub97c \ucc28\uc9c0\ud588\uace0, \uc804\uc784\uc0c1 \ud504\ub85c\uc81d\ud2b8(Pre-clinical projects)\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.54%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 2025\ub144 42.65%\uc758 \uc810\uc720\uc728\uc744 \uae30\ub85d\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.54%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c API CDMO \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30:<\/p>\n<p>\uc131\uc7a5 \ub3d9\ub825:<br \/>\n*   \uae00\ub85c\ubc8c \uc758\uc57d\ud488 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5: 2025\ub144 \uc804 \uc138\uacc4 \uc784\uc0c1 \ud30c\uc774\ud504\ub77c\uc778\uc740 21,000\uac1c \uc774\uc0c1\uc758 \ud65c\uc131 \ubd84\uc790\ub85c, 2024\ub144 \ub300\ube44 12% \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc885\uc591\ud559, \uba74\uc5ed\ud559, \ud76c\uadc0 \uc9c8\ud658 \ubd84\uc57c\uac00 2\uc0c1 \ubc0f 3\uc0c1 \ud504\ub85c\uadf8\ub7a8\uc758 60%\ub97c \ucc28\uc9c0\ud569\ub2c8\ub2e4. \ubbf8\uad6d FDA\ub294 2024\ub144\uc5d0 55\uac1c\uc758 \uc2e0\uaddc \ubd84\uc790 \ubb3c\uc9c8\uc744 \uc2b9\uc778\ud588\uc73c\uba70, \uc774\ub294 2018\ub144 \uc774\ud6c4 \ucd5c\uace0\uce58\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ucd94\uc138\ub294 \uc790\uccb4 \uc0dd\uc0b0 \uc5ed\ub7c9\uc758 \ud55c\uacc4\ub97c \ucd08\ub798\ud558\uc5ec \uc81c\uc57d\uc0ac\ub4e4\uc774 \ucd08\uae30 \ub2e8\uacc4 \ubc0f \uc0c1\uc5c5\uc801 \uacf5\uae09\uc744 \uc704\ud574 CDMO\uc640\uc758 \ud611\ub825\uc744 \ubaa8\uc0c9\ud558\uac8c \ud569\ub2c8\ub2e4. WuXi AppTec\uc740 2024\ub144 \uc18c\ubd84\uc790 API \ud504\ub85c\uc81d\ud2b8\uac00 \uc804\ub144 \ub300\ube44 28% \uc99d\uac00\ud588\ub2e4\uace0 \ubcf4\uace0\ud588\uc73c\uba70, \uc774\ub294 \ubc14\uc774\uc624\ud14d \uace0\uac1d\ub4e4\uc758 \ucd08\uae30 \uc784\uc0c1 \uc5f0\uad6c \uc9c4\uc804\uc5d0 \ud798\uc785\uc740 \ubc14 \ud07d\ub2c8\ub2e4.<br \/>\n*   \uace0\ud6a8\ub2a5 \ubc0f \ubcf5\ud569 \ubd84\uc790\ub85c\uc758 \uc804\ud658: \ub178\ucd9c \ud55c\uacc4 10 \u00b5g\/m\u00b3 \ubbf8\ub9cc\uc73c\ub85c \ucde8\uae09\ub418\ub294 \uace0\ud6a8\ub2a5 API(HPAPI)\ub294 \uc815\ubc00 \uc885\uc591\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ubc0f \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC) \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud798\uc785\uc5b4 2025\ub144 \uc2e0\uaddc API \ub4f1\ub85d\uc758 24%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4(2024\ub144 18%). Olon\uc740 2024\ub144 \uc774\ud0c8\ub9ac\uc544\uc5d0 2,500\ub9cc \uc720\ub85c(2,700\ub9cc \ub2ec\ub7ec)\ub97c \ud22c\uc790\ud558\uc5ec 0.1 \u00b5g\/m\u00b3 \uc218\uc900\uc758 \ud398\uc774\ub85c\ub4dc\ub97c \ucc98\ub9ac\ud560 \uc218 \uc788\ub294 \uc544\uc774\uc194\ub808\uc774\ud130 \uc2a4\uc704\ud2b8\ub97c \uac16\ucd98 HPAPI \uacf5\uc7a5\uc744 \uac00\ub3d9\ud588\uc2b5\ub2c8\ub2e4. HPAPI \uc11c\ube44\uc2a4\ub294 \ud45c\uc900 API\ubcf4\ub2e4 40~60% \ub192\uc740 \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9\uc744 \ud615\uc131\ud558\uc5ec API CDMO \uc2dc\uc7a5\uc758 \ud575\uc2ec \uc218\uc775 \ub3d9\ub825\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<br \/>\n*   \ud488\uc9c8 \ubc0f \uaddc\uc81c \uc900\uc218 \uc555\ub825: \ubbf8\uad6d FDA\ub294 2024\ub144 API \uacf5\uc7a5\uc5d0 18\uac74\uc758 \uacbd\uace0 \uc11c\ud55c\uc744 \ubc1c\ud589\ud588\uc73c\uba70, \uc774 \uc911 72%\uac00 \ub370\uc774\ud130 \ubb34\uacb0\uc131 \ubb38\uc81c\ub97c \uc9c0\uc801\ud588\uc2b5\ub2c8\ub2e4. 2024\ub144 \ubc1c\ud6a8\ub41c EU GMP Annex 1 \ubb34\uade0 API \uaddc\uc815 \uac1c\uc815\uc548\uacfc 2025\ub144 1\uc6d4 \uc11c\uba85\ub41c \ubbf8\uad6d \uc804\ub7b5 API \ube44\ucd95 \ud589\uc815 \uba85\ub839\uc740 ISO 9001 \ubc0f ICH Q7 \uc778\uc99d \ud45c\uc900\uc744 \uc774\ubbf8 \ucda9\uc871\ud558\ub294 CDMO\ub85c \uc81c\uc57d\uc0ac\ub4e4\uc744 \uc720\ub3c4\ud558\uace0\uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc81c\uc57d\uc0ac\ub4e4\uc774 API \uacf5\uae09\ub9dd\uc758 \uc548\uc815\uc131\uacfc \ud488\uc9c8\uc744 \ud655\ubcf4\ud558\uae30 \uc704\ud574 \ub354\uc6b1 \uc5c4\uaca9\ud55c \uae30\uc900\uc744 \uc694\uad6c\ud558\uac8c \ub9cc\ub4e4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc9c0\uc815\ud559\uc801 \uc704\ud5d8 \ubc0f \uacf5\uae09\ub9dd \ub2e4\uac01\ud654: 2024\ub144 \ubbf8\uad6d\uc740 \uc911\uad6d\uacfc \uc778\ub3c4\uc5d0 \ub300\ud55c API \uc758\uc874\ub3c4\ub97c \uc904\uc774\uae30 \uc704\ud574 \uad6d\ub0b4 API \uc0dd\uc0b0\uc5d0 1\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc2b5\ub2c8\ub2e4. \ub610\ud55c, 2024\ub144 10\uc6d4 \uc774\uc2a4\ub77c\uc5d8-\ud558\ub9c8\uc2a4 \ubd84\uc7c1\uc73c\ub85c \uc778\ud574 \uc911\ub3d9 \uc9c0\uc5ed\uc758 API \uacf5\uae09\ub9dd\uc774 \uc77c\uc2dc\uc801\uc73c\ub85c \uc911\ub2e8\ub418\uba74\uc11c, \uc81c\uc57d\uc0ac\ub4e4\uc740 \uacf5\uae09\ub9dd \ub2e4\uac01\ud654 \ubc0f \uc9c0\uc5ed\ud654 \uc804\ub7b5\uc744 \uc801\uadf9\uc801\uc73c\ub85c \ubaa8\uc0c9\ud558\uac8c \ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub294 CDMO\ub4e4\uc774 \uc5ec\ub7ec \uc9c0\uc5ed\uc5d0 \uc0dd\uc0b0 \uc2dc\uc124\uc744 \uac16\ucd94\uace0 \uc788\uac70\ub098, \ud2b9\uc815 \uc9c0\uc5ed\uc758 \uacf5\uae09\ub9dd \uc704\ud5d8\uc744 \uad00\ub9ac\ud560 \uc218 \uc788\ub294 \uc5ed\ub7c9\uc744 \uac16\ucd94\ub294 \uac83\uc774 \uc911\uc694\ud574\uc9c0\uace0 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>*   \uc9c0\uc18d \uac00\ub2a5\uc131 \ubc0f ESG(\ud658\uacbd, \uc0ac\ud68c, \uc9c0\ubc30\uad6c\uc870) \uc555\ub825: \uc81c\uc57d \uc0b0\uc5c5\uc740 \ud0c4\uc18c \ubc30\ucd9c\ub7c9 \uac10\uc18c, \ud3d0\uae30\ubb3c \uad00\ub9ac, \uc218\uc790\uc6d0 \ubcf4\uc874 \ub4f1 \ud658\uacbd\uc801 \uc9c0\uc18d \uac00\ub2a5\uc131\uc5d0 \ub300\ud55c \uc555\ub825\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA)\uc740 \uc81c\uc57d\uc0ac\uc5d0 API \uc0dd\uc0b0 \uacfc\uc815\uc758 \ud658\uacbd \uc601\ud5a5\uc744 \ud3c9\uac00\ud558\uace0 \ubcf4\uace0\ud558\ub3c4\ub85d \uc758\ubb34\ud654\ud558\ub294 \uc0c8\ub85c\uc6b4 \uc9c0\uce68\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4. \uc774\uc5d0 \ub530\ub77c CDMO\ub4e4\uc740 \uce5c\ud658\uacbd \uacf5\uc815 \uac1c\ubc1c, \uc7ac\uc0dd \uc5d0\ub108\uc9c0 \uc0ac\uc6a9, \ud3d0\uae30\ubb3c \uc7ac\ud65c\uc6a9 \ub4f1 ESG \uacbd\uc601\uc744 \uac15\ud654\ud558\uc5ec \uc81c\uc57d\uc0ac\ub4e4\uc758 \uc9c0\uc18d \uac00\ub2a5\uc131 \ubaa9\ud45c \ub2ec\uc131\uc744 \uc9c0\uc6d0\ud574\uc57c \ud569\ub2c8\ub2e4. \uc774\ub294 \uc7a5\uae30\uc801\uc73c\ub85c CDMO\uc758 \uacbd\uc7c1\ub825\uacfc \uc2dc\uc7a5 \uac00\uce58\ub97c \ub192\uc774\ub294 \uc911\uc694\ud55c \uc694\uc18c\uac00 \ub420 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ud65c\uc131 \uc758\uc57d\ud488 \uc131\ubd84(API) CDMO(Contract Development and Manufacturing Organization) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. API\ub294 \uc758\uc57d\ud488\uc758 \ud575\uc2ec \uc720\ud6a8 \uc131\ubd84\uc73c\ub85c, \uc804\ud1b5\uc801\uc73c\ub85c \uc81c\uc57d\uc0ac\ub4e4\uc774 \uc790\uccb4 \uc0dd\uc0b0\ud588\uc73c\ub098 \ucd5c\uadfc\uc5d0\ub294 \ud22c\uc790 \uc218\uc775\ub960 \ubc0f \ud6a8\uc728\uc131 \uc99d\ub300\ub97c \uc704\ud574 CDMO\uc5d0 \uc704\ud0c1\ud558\ub294 \ucd94\uc138\uac00 \ud655\uc0b0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8\ub294 2026\ub144 1,393\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 2,105\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uae00\ub85c\ubc8c \uc2e0\uc57d \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc9c0\uc18d\uc801\uc778 \ud655\uc7a5, \uace0\ud6a8\ub2a5 \ubc0f \ubcf5\ud569 \ubd84\uc790(HPAPI)\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654, \ud488\uc9c8 \ubc0f \uaddc\uc81c \uc900\uc218\uc5d0 \ub300\ud55c \uc555\ub825 \uc99d\uac00, \uc544\uc6c3\uc18c\uc2f1\uc744 \ud1b5\ud55c \ube44\uc6a9 \ucd5c\uc801\ud654 \ubc0f \uc0dd\uc0b0 \uc720\uc5f0\uc131 \ud655\ubcf4, \ud601\uc2e0\uc801\uc778 \uc81c\uc870 \uae30\uc220(\uc5f0\uc18d \ud750\ub984 \ubc18\uc751\uae30, \uc0dd\uccb4 \ucd09\ub9e4, \uc77c\ud68c\uc6a9 \ubc1c\ud6a8\uae30 \ub4f1)\uc758 \ucc44\ud0dd, \uadf8\ub9ac\uace0 \uc9c0\uc18d \uac00\ub2a5\uc131 \ubc0f \ud0c4\uc18c \uac10\ucd95 \ubaa9\ud45c\uac00 \uacf5\uae09\uc5c5\uccb4 \uc120\uc815\uc5d0 \ubbf8\uce58\ub294 \uc601\ud5a5 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \ud56d\uc554 \ud30c\uc774\ud504\ub77c\uc778 \ubc0f \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC)\uc758 \uc218\uc694 \uc99d\uac00\ub85c \uace0\ud6a8\ub2a5 API \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.32%\uc758 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub610\ud55c, \uae30\uc220 \uc774\uc804 \uc2dc\uac04 \ub2e8\ucd95\uacfc \ub2e8\uc77c \uacf5\uae09\uc6d0 \ucc45\uc784\uc758 \uc774\uc810 \ub54c\ubb38\uc5d0 \ud1b5\ud569 \uc5d4\ub4dc-\ud22c-\uc5d4\ub4dc CDMO \uc11c\ube44\uc2a4\uc5d0 \ub300\ud55c \uc120\ud638\ub3c4\uac00 \ub192\uc544\uc838, \ud574\ub2f9 \ubd80\ubb38\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 10.33% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ud575\uc2ec \uc6d0\ub8cc\uc758 \uacf5\uae09\ub9dd \ucde8\uc57d\uc131, \uc81c\ub124\ub9ad \uc758\uc57d\ud488\uc758 \uac00\uaca9 \ud558\ub77d\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15, \uc5c4\uaca9\ud55c \ud658\uacbd \ubc0f \uc548\uc804 \uaddc\uc81c \uc900\uc218 \ube44\uc6a9 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc219\ub828\ub41c \uacf5\uc815 \ud654\ud559\uc790 \ubc0f \uc5d4\uc9c0\ub2c8\uc5b4\uc758 \ubd80\uc871 \ub4f1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uc778\ub3c4\uc758 \ube44\uc6a9 \uacbd\uc7c1\ub825\uacfc \ubc14\uc774\uc624\uc758\uc57d\ud488 \ubc0f \ud3a9\ud0c0\uc774\ub4dc \uc0dd\uc0b0 \ub2a5\ub825 \ud655\ucda9\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 9.54%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \ubd81\ubbf8, \uc720\ub7fd, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed \ub610\ud55c \uc0c1\uc138\ud558\uac8c \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\uaddc\uc81c \ud658\uacbd \uce21\uba74\uc5d0\uc11c\ub294 BIOSECURE Act\uc640 \uac19\uc740 \ubc95\uc548\uc774 \ud2b9\uc815 \uc911\uad6d CDMO\ub85c\ubd80\ud130\uc758 \ubbf8\uad6d \uc5f0\ubc29 \uc870\ub2ec\uc744 \uc81c\ud55c\ud568\uc73c\ub85c\uc368, \uc81c\uc57d\uc0ac\ub4e4\uc774 \uacf5\uae09\ub9dd\uc744 \uc778\ub3c4, \ubd81\ubbf8, \uc720\ub7fd \ub4f1\uc73c\ub85c \uc7ac\uc870\uc815\ud558\ub294 \uc911\uc694\ud55c \uacc4\uae30\uac00 \ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uae00\ub85c\ubc8c API \uc18c\uc2f1 \uc804\ub7b5\uc5d0 \uc0c1\ub2f9\ud55c \uc601\ud5a5\uc744 \ubbf8\uce60 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ubd84\uc790 \ud06c\uae30(\uc18c\ubd84\uc790, \ub300\ubd84\uc790\/\uc0dd\ubb3c\ud559\uc801 \ubd84\uc790), \ud569\uc131 \uc720\ud615(\ud569\uc131 \ud654\ud559, \uc0dd\ubb3c\ud559\uc801), API \ubcf5\uc7a1\uc131(\ud45c\uc900 \ud6a8\ub2a5, \uace0\ud6a8\ub2a5), \uc11c\ube44\uc2a4 \uc720\ud615(\uacf5\uc815 R&#038;D \ubc0f \uacbd\ub85c \ud0d0\uc0c9, cGMP \uc2a4\ucf00\uc77c\uc5c5 \ubc0f \uc0c1\uc5c5 \uc0dd\uc0b0, \ud1b5\ud569 \uc5d4\ub4dc-\ud22c-\uc5d4\ub4dc \uc11c\ube44\uc2a4), \uce58\ub8cc \uc601\uc5ed(\uc885\uc591\ud559, \uc2ec\ud608\uad00 \ubc0f \ub300\uc0ac, \ud56d\uac10\uc5fc\uc81c \ub4f1), \uace0\uac1d \uc720\ud615(\ub300\ud615 \uc81c\uc57d\uc0ac, \uc911\uacac \uc81c\uc57d\uc0ac, \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\ud14d \ub4f1), \uac1c\ubc1c \ub2e8\uacc4(\uc804\uc784\uc0c1, \uc784\uc0c1 1~3\uc0c1, \uc0c1\uc5c5\ud654) \ub4f1 \ub2e4\uc591\ud55c \uae30\uc900\uc73c\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728, \uadf8\ub9ac\uace0 Ajinomoto Bio-Pharma Services, Lonza Group AG, Samsung Biologics, WuXi AppTec Co., Ltd.\ub97c \ud3ec\ud568\ud55c 23\uac1c \uc8fc\uc694 \uae30\uc5c5\uc758 \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud558\uc5ec \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc758 \uc804\ub7b5\uc801 \uc774\ud574\ub97c \ub3d5\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860\uc801\uc73c\ub85c, API CDMO \uc2dc\uc7a5\uc740 \ud601\uc2e0\uc801\uc778 \uae30\uc220\uacfc \ubcc0\ud654\ud558\ub294 \uaddc\uc81c \ud658\uacbd \uc18d\uc5d0\uc11c \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc774 \uc608\uc0c1\ub418\uba70, \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \ud30c\uc545\ud558\uace0 \ubbf8\ub798 \uae30\ud68c\ub97c \ubaa8\uc0c9\ud558\ub294 \uac83\uc774 \uc911\uc694\ud558\ub2e4\uace0 \uac15\uc870\ub429\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58477","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/58477"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=58477"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/58477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=58477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=58477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=58477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}